Ryuhei So, Masaru Tsukahara, Shinichiro Nakajima, Hiroyoshi Takeuchi. Restarting Smoking After Discharge from Clozapine In-Patient Initiation: Elevated Rehospitalization Rates. Psychiatry and clinical neurosciences. 2023
Masaru Tsukahara, Ryuhei So, Yusaku Yoshimura, Rieko Yamashita, Yuji Yada, Masafumi Kodama, Shinichiro Nakajima, Yoshiki Kishi, Toshihiko Takeda, Norihito Yamada, et al. Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study. Acta psychiatrica Scandinavica. 2023
Masataka Wada, Hideaki Yasuda, Shinichiro Nakajima, Takahide Etani, Akihiko Miura, Shintaro Asada, Kazunari Yoshida, Yoshihiro Noda, Hiroyoshi Takeuchi. Efficacy and moderators of prevention and treatment of delirium with melatonin receptor agonists: A systematic review and meta-analysis of randomized controlled trials. General hospital psychiatry. 2023. 85. 71-79
Yasuharu Yamamoto, Keisuke Takahata, Manabu Kubota, Hiroyoshi Takeuchi, Sho Moriguchi, Takeshi Sasaki, Chie Seki, Hironobu Endo, Kiwamu Matsuoka, Kenji Tagai, et al. Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brain. European journal of nuclear medicine and molecular imaging. 2023
Yumi Aoki, Yoshikazu Takaesu, Kentaro Matsui, Takahiro Tokumasu, Hideaki Tani, Yoshiteru Takekita, Tetsufumi Kanazawa, Taishiro Kishimoto, Seiichiro Tarutani, Naoki Hashimoto, et al. Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia. Neuropsychopharmacology reports. 2023. 43. 3. 391-402
